Judge OKs Glaxo's $65M Settlement Of Antitrust Suit Over Paxil Patent Gaming

Law360, New York (April 27, 2005, 12:00 AM EDT) -- A federal judge has approved SmithKline Beecham's $65 million settlement of a class-action antitrust suit brought by consumers who accused the U.K. drug maker of filing "sham" patent lawsuits to delay generic competition for antidepressant Paxil.

U.S. District Judge John R. Padova approved the settlement and awarded $19 million in attorney fees to a team of plaintiffs lawyers, led by attorneys Ellen Meriwether of Miller Faucher & Cafferty in Philadelphia, Dianne M. Nast of Roda Nast in Lancaster, Pa., and Kenneth A. Wexler of The Wexler...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.